e.l.f. Beauty에 대한 매도 수량은 투자자에게 e.l.f. Beauty의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

e.l.f. Beauty (NYSE:ELF) 주식, 공매도 수량 보고

e.l.f. Beauty

e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.

News

Short Sellers

Short Ideas

Movers

Trading Ideas

머디 워터스 리서치(Muddy Waters Research)의 창립자인 카슨 블록(Carson Block)이 수요일 손(Sohn) 컨퍼런스에서 엘프 뷰티(NYSE:ELF)에 대한 새로운 공매도 포지션을 발표하면서 해당 화장품 회사의 주가가 급락했다. 이 공매도 세력이 엘프(E.L.F.)에 대해 반대 베팅을 하는 이유를 살펴보겠다.

공매도 세력인 머디 워터스의 카슨 블록이 엘프 뷰티의 재무제표가 &#39;주요 적신호&#39;라고 주장

Earnings

엘프 뷰티(NYSE:ELF) 주가는 수요일(6일) 장 마감 후 2분기 실적을 발표하고난 이후 상승 중이다. 실적 보고서의 세부 사항을 살펴보자.세부 사항: 엘프 뷰티의 분기 주당순이익은 77센트이며, 이는 애널리스트 컨센서스 예상치 42센트를 초과한 수치다. 분기 매출은 3억 1,110만 달러로, 애널리스의 컨센서스 예상치 2억 8,576만 달러를 초과했고, 전년 동기 매출 2억 1,550만 달러에 비해 증가한 수준이다.

엘프 뷰티, 강력한 2분기 실적으로 주가 급등

After-Hours Center

엘프 뷰티(NYSE:ELF)의 주가는 회사가 목요일 1분기 재무 결과를 발표한 후 하락했다. 보고서의 세부 정보는 다음과 같다. 주요 정보: 엘프 뷰티(E.l.f. Beauty)는 분기별 이익을 주당 1.10달러로 보고했는데, 이는 애널리스트 컨센서스 추정치인 84센트를 30.95%나 앞선 수치이다.

엘프 뷰티의 주식은 양호한 1분기 실적과 연간 지침에도 10% 이상 하락

e.l.f. Beauty Inc

aelf

E-L Financial Corp Ltd

On Wednesday, November 20, U.S. markets closed mixed. The Nasdaq slipped, weighed down by geopolitical tensions and Target&#8217;s disappointing performance. Nvidia declined ahead of earnings, which later underwhelmed. Meanwhile, the Dow edged higher, and the S&amp;P 500 remained flat.
In economic data, U.S. mortgage applications increased by 1.7% for the week ending November 15, up from the 0.5% rise recorded the previous week.
Healthcare, energy, and materials led S&amp;P 500 gains Wednesday, while consumer discretionary and financials declined.
The Dow Jones Industrial Average was up 0.32% and closed at 43,408.47, the S&amp;P 500 gained 0.002% to 5,917.11, and the Nasdaq Composite declined 0.11% to finish at 18,966.14.
Asia Markets Today
<ul>
<li>On Thursday, Japan&#8217;s Nikkei 225 declined 0.97% and ended the session at 38,002.50, led by losses in the Insurance, Transportation Equipment, and Power sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.04% and ended the day at 8,323.00, led by losses in the Consumer Discretionary, Consumer Staples, and A-REITs sectors.</li>
<li>India&#8217;s Nifty 50 declined 0.73% to 23,346.70, and Nifty 500 slid 0.85% closing at 21,816.45, led by losses in the Public Sector Undertakings, Oil &amp; Gas and Power sectors.</li>
<li>China&#8217;s Shanghai Composite gained 0.07% to close at 3,370.40, and the Shenzhen CSI 300 rose 0.09%, finishing the day at 3,989.30.</li>
<li>Hong Kong&#8217;s Hang Seng fell 0.53% and closed the session at 19,601.11.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 index was down 0.36%.</li>
<li>Germany&#8217;s DAX slid 0.02%.</li>
<li>France&#8217;s CAC declined 0.43%.</li>
<li>FTSE 100 index traded higher by 0.20%</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 1.70% at $69.94/bbl, and Brent was up 1.58% at $73.95/bbl.</li>
<li>Oil prices rose amid escalating Russia-Ukraine missile strikes, overshadowing a larger-than-expected U.S. crude inventory increase.</li>
<li>Natural Gas rose 6.45% to $3.297.</li>
<li>Gold was trading higher by 0.78% at $2,672.45, Silver was up 0.35% to $31.115, and Copper fell 0.83% to $4.1210.</li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures declined 0.07%, S&amp;P 500 futures were down 0.24% and Nasdaq 100 futures fell 0.35%.
Forex at 05:30 AM ET
The U.S. dollar index gained 0.04% to 106.72, the USD/JPY was down 0.64% to 154.44, and the USD/AUD slid 0.08% to 1.5357.
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed; Dollar Hovers Near 52-Week High - Global Markets Today While US Slept

Throughout this NFL-style, three-day combine, prospects from nearly every state are expected to attend, with this year's event expected to host the largest total number of recruits in the event's history and the largest combine-style event in the country.
In connection with their participation in the event, all student-athletes will receive a complimentary one-month trial of the Signing Day Sports app, enhancing their visibility to college recruiters.
By collecting registration fees and offering exclusive apparel for participants and fans, the combine enables the Company to drive immediate income while strengthening its brand presence.&nbsp;
&nbsp;

Signing Day Sports Provides Update On Upcoming 3rd Annual US Army Bowl National Combine; Says Combine Enables Company To Drive Immediate Income While Strengthening Its Brand Presence

China Renaissance analyst Yiwen Zhang downgrades Grab Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) from Buy to Hold and announces $5.4 price target.

Downgrades

Price Target

Analyst Ratings

GRAB

China Renaissance Downgrades Grab Holdings to Hold, Announces $5.4 Price Target

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lisata Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) with a Buy and maintains $15 price target.

Reiteration

LSTA

HC Wainwright & Co. Reiterates Buy on Lisata Therapeutics, Maintains $15 Price Target

Needham analyst Mike Cikos maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Buy and raises the price target from $160 to $200.

SNOW

Needham Maintains Buy on Snowflake, Raises Price Target to $200

<ul>
<li>Aphexda is Biolinerx's FDA-Approved Stem Cell Mobilization Agent Indicated In Combination With Filgrastim For Collection And Subsequent Autologous Transplantation In Patients With Multiple Myeloma.</li>
<li>BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to $87 million in commercial milestones, as well as royalties on net sales ranging from 18% to 23%.</li>
<li>BioLineRx retains rights to develop and commercialize motixafortide in solid tumors, including PDAC.</li>
<li>BioLineRx received $9 million equity investment from certain funds managed by Highbridge Capital Management, LLC to support company's pipeline and expansion.</li>
<li>Transactions enable significant reduction in BioLineRx's operational expenses and debt, and allow the company to focus on development activities in areas of high unmet need in oncology and rare diseases –</li>
</ul>

Biotech

Health Care

Contracts

General

BLRX

BioLineRx And Ayrmid Entered Into A License Agreement For Motixafortide (Commercially Sold In The US As Aphexda), BioLineRx Will Receive A $10M Upfront Payment And Is Also Eligible To Receive Up To An Additional $87M Of Potential Commercial Milestones, Plus Royalties Between 18%-23% On Net Sales Of Aphexda

Trimble will provide fleet management and telematics solutions to vehicles across PFG's three business segments including Performance Foodservice Core-Mark and Vistar.&nbsp;
All PFG vehicles will be equipped with Trimble Instinct, Trimble's in-cab ecosystem that seamlessly connects drivers and back-office staff to boost safety, compliance and efficiency.
 &nbsp;

PFGC

TRMB

Performance Food Group Selects Trimble As Its Premier Fleet Management Provider; Migrates 100% Of Its Fleet Management Business To Trimble Instinct, Doubling Trimble-Serviced Trucks To Over 8,000

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDD Holdings Q3 Adj EPADS $2.65 Misses $2.82 Estimate, Sales $14.16B Miss $14.47B Estimate

Artificial intelligence (AI) darling Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) <a href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam">beat expectations yet again</a> with impressive third-quarter revenue and earnings reported after Wednesday's market close. 
What happened: The world's most valuable company <a href="https://www.benzinga.com/24/11/42099904/nvidia-q3-earnings-highlights">disclosed </a>third-quarter revenue of $35.1 billion and earnings per share of 81 cents, both beating analysts' estimates.&nbsp;
The Jensen Huang-led firm has had a blockbuster run on equity markets in the last few years, multiplying investors' money by orders of magnitude.&nbsp;
Indeed, Nvidia shares have exploded by 2,718% in the last five years, outperforming all well-known companies on Wall Street.
In comparison, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)—the world's most valued cryptocurrency exerting a similar influence on the digital assets market—grew 1,171% over the last five years.
See Also: <a href="https://www.benzinga.com/24/11/42079799/microstrategys-michael-saylor-to-advocate-for-bitcoin-investment-at-microsoft-board-meeting-offers-to-educate-rumble-ceo-with-the-strategy">Microstrategy&#8217;s Michael Saylor To Advocate For Bitcoin At Microsoft Board Meeting, Offers To Educate Rumble CEO As Well</a>
<h2 class="wp-block-heading">Which Is Offering Better Returns Relative To Risk?</h2>
Both Nvidia and Bitcoin are risk-laden investments, and traders must navigate their inherent volatility to profit.
To get a more accurate picture, analysts track the Sharpe Ratio, a measure of risk-adjusted returns. 
For Bitcoin, this ratio stood at -5 as of this writing, <a href="https://in.tradingview.com/chart/XlzxagWe/?symbol=BITSTAMP%3ABTCUSD">per </a>TradingView, implying that the expected return was lower than that of a risk-free investment, such as a Treasury yield.&nbsp;
On the other hand, Nvidia <a href="https://www.tradingview.com/chart/XlzxagWe/?symbol=NASDAQ%3ANVDA">showed </a>a Sharpe ratio of 0.69, indicating that investment in the stock was generating positive returns above the risk-free rate.
<h2 class="wp-block-heading">Are Their Valuations Inflated?</h2>
Another metric to compare the two hot financial assets was whether they were expensive or cheap relative to their fundamentals.
For stocks, this is typically measured by the price-to-earnings ratio, or simply the P/E ratio.&nbsp;
Nvidia's P/E ratio showed a reading of 73.478 per TradingView, suggesting that the stock was highly overpriced. It could also imply that investors expect the company to have stronger performance and higher earnings in the future.
The P/E counterpart for Bitcoin is the network value to transactions ratio or NVT ratio.
According to on-chain analytics firm <a href="https://cryptoquant.com/asset/btc/chart/network-indicator/nvt-ratio?window=DAY&amp;sma=0&amp;ema=0_30&amp;priceScale=log&amp;metricScale=log&amp;chartStyle=column">CryptoQuant</a>, the 30-day EMA of Bitcoin's NVT was at 28.28 at the time of writing, a decline from 36.32 recorded at the beginning of the month.
The decline implied that transaction volume was outperforming market growth or that valuation had dropped without any change in transaction activity.
Price Action: At the time of writing, Bitcoin was trading at $97,396.60, rising 4.97% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Shares of Nvidia were down 2.49% in after-hours trading.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42079984/dogecoin-bitcoin-left-in-the-dust-by-ai-meme-coin-goat-as-nvidias-q3-earnings-draw-near">Dogecoin, Bitcoin Left In The Dust By AI Meme Coin GOAT As Nvidia&#8217;s Q3 Earnings Draw Near</a></li>
</ul>
Photos courtesy: Nvidia and Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Tech

$BTC

NVDA

Nvidia Vs. Bitcoin: Jensen Huang-Led Chip Giant's Stock Outperformed The Top Cryptocurrency Over 5 Years. Here's How They Compare On Other Metrics

Benchmark analyst Cody Acree maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $170 to $190.

Benchmark Maintains Buy on NVIDIA, Raises Price Target to $190

Roth MKM analyst Joe Reagor initiates coverage on Stardust Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) with a Buy rating and announces Price Target of $13.

Initiation

SDST

Roth MKM Initiates Coverage On Stardust Power with Buy Rating, Announces Price Target of $13

Morgan Stanley analyst James Faucette upgrades Evertec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTC#NYSE">EVTC</a>) from Underweight to Equal-Weight and raises the price target from $33 to $35.

Upgrades

EVTC

Morgan Stanley Upgrades Evertec to Equal-Weight, Raises Price Target to $35

Morgan Stanley analyst Brian Wilczynski initiates coverage on UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) with a Overweight rating and announces Price Target of $156.

UMBF

Morgan Stanley Initiates Coverage On UMB Financial with Overweight Rating, Announces Price Target of $156

Needham analyst Quinn Bolton maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $145 to $160.

Needham Maintains Buy on NVIDIA, Raises Price Target to $160

Morgan Stanley analyst Judah Frommer initiates coverage on 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Underweight rating and announces Price Target of $8.

FDMT

Morgan Stanley Initiates Coverage On 4D Molecular Therapeutics with Underweight Rating, Announces Price Target of $8

Morgan Stanley analyst Judah Frommer initiates coverage on Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Equal-Weight rating and announces Price Target of $31.

APLS

Morgan Stanley Initiates Coverage On Apellis Pharmaceuticals with Equal-Weight Rating, Announces Price Target of $31

Quantum-Si Provides Update On Innovation Roadmap & New Development Partnerships; Announces Next-Generation Platinum System, The Platinum Pro, Scheduled To Launch In H1 Of 2025

Guidance

SCVL

Shoe Carnival Lowers FY24 Net Sales Outlook: Sees Revenues Of $1.20B-$1.23B Vs $1.23B Estimate (Prior View:  $1.23B-$1.25B); Company Reiterates FY24 Adjusted EPS Outlook Of $2.60-$2.75 Vs. $2.63 Estimate

With more than a week of deals planned across the entire assortment, Target will offer some of its lowest prices of the season on thousands of items, including up to 50% off tech, apparel, video games, board games, small appliances, luggage, holiday trees and other must-have items for gifting and gathering.

Target Reveals Its Lineup Of Black Friday Deals Available Now Through Nov. 30 Online And In Its Stores

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) with a Buy and raises the price target from $4 to $5.5.

HC Wainwright & Co. Maintains Buy on Quantum-Si, Raises Price Target to $5.5

e.l.f. Beauty, Inc. (ELF) has disclosed a new risk, in the Share Price & Shareholder Rights category. e.l.f. Beauty, Inc. faces uncertainty with it...

e.l.f. Beauty's 2024 Share Buyback Plan: Navigating Market Uncertainty and Financial Implications

Coty: With The Makeover Now Complete, This Prospect Is A Beauty

The 2024 Q3 earnings cycle is slowly wrapping up, with the bulk of S&P 500 companies already revealing quarterly results.

This Top AI Stock Crushed Quarterly Expectations

Analyst Dara Mohsenian from Morgan Stanley maintained a Hold rating on e.l.f. Beauty (ELF – Research Report) and keeping the price target at $139.0...

Cautious Hold: Balancing e.l.f. Beauty's Market Growth with Stock Price Uncertainty

JPMorgan's 'Analyst Focus List' – growth, income, value, short ideas

e.l.f. Beauty drops after short call from Muddy Waters at charity conference

11:32 EST Elf Beauty (ELF) down 8% after Muddy Waters short report Published first on TheFly – the ultimate source for real-time, market-moving bre...

Elf Beauty down 8% after Muddy Waters short report

11:32 EST Muddy Waters short Elf Beauty (ELF), sees ‘revenue and inventory mystery' Published first on TheFly – the ultimate source for real-time, ...

Muddy Waters short Elf Beauty, sees 'revenue and inventory mystery'

Bearish flow noted in E.l.f. Beauty with 8,204 puts trading, or 3x expected. Most active are 11/22 weekly 111 puts and 11/22 weekly 125 calls, with...

E.l.f. Beauty put volume heavy and directionally bearish

Muddy Waters is short e.l.f. Beauty because the firm believes the company has "materially overstated revenue over the past three quarters – possibl...

Elf Beauty slides after Muddy Waters goes short, questions revenue

AGCO

ALRM

AMZN

ARMK

ASND

AVGO

BRBR

COTY

CVNA

CYBR

DAWN

DELL

DKNG

EWTX

GWRE

IPAR

ISRG

KLAC

KVUE

LEGN

MNDY

MSFT

NTRA

PLTR

PODD

ROIV

RVMD

SCHW

SIRI

SNDX

SPGI

SWTX

TFII

TMUS

TRGP

TVTX

ULTA

VICI

XENE

Press Releases

Breaking the Ice: e.l.f. Cosmetics Partners Up with Toronto Maple Leafs

e.l.f. Cosmetics Releases Full 'Get Ready With Music, The Album,' Giving a Megaphone to Emerging Artists

e.l.f. Beauty's New Challenge: 'Dupe That!', an Invitation to Other Companies to Join the Unicorn Parade to Make Positive Impacts

e.l.f. Beauty Announces Earnings Release Date for Second Quarter Fiscal 2025 Results

Keys Soulcare Unveils Enhancing Shades of Let Me Glow Illuminating Serum

e.l.f. Beauty Announces Second Quarter Fiscal 2025 Results

e.l.f. Cosmetics and Beekman 1802 Join Forces for World Kindness Day in Roblox

e.l.f. Cosmetics is Causing an e.l.f.ing Racket at the Billie Jean King Cup

Rosen Law Firm Encourages e.l.f. Beauty, Inc. Investors to Inquire About Securities Class Action Investigation – ELF

Legal

e.l.f. Beauty Is Now Under Investigation by Johnson Fistel on Behalf of Shareholders Who Incurred Losses on Their Investment

Comments

e.l.f. Beauty

매도 수량

e.l.f. Beauty (NYSE:ELF) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌